TY - JOUR
T1 - Genetic/familial high-risk assessment
T2 - Breast and ovarian - Clinical practice guidelines in oncology™
AU - Daly, Mary B.
AU - Axilbund, Jennifer E.
AU - Buys, Saundra
AU - Crawford, Beth
AU - Farrell, Carolyn D.
AU - Friedman, Susan
AU - Garber, Judy E.
AU - Goorha, Salil
AU - Gruber, Stephen B.
AU - Hampel, Heather
AU - Kaklamani, Virginia
AU - Kohlmann, Wendy
AU - Kurian, Allison
AU - Litton, Jennifer
AU - Marcom, P. Kelly
AU - Nussbaum, Robert
AU - Offit, Kenneth
AU - Pal, Tuya
AU - Pasche, Boris
AU - Pilarski, Robert
AU - Reiser, Gwen
AU - Shannon, Kristen Mahoney
AU - Smith, Jeffrey R.
AU - Swisher, Elizabeth
AU - Weitzel, Jeffrey N.
PY - 2010/5
Y1 - 2010/5
N2 - All cancers develop as a result of mutations in certain genes, such as those involved in the regulation of cell growth and/or DNA repair, but not all mutations are inherited. However, family studies have long documented an increased risk for several forms of cancer among first and second-degree relatives . Hereditary cancers are often characterized by mutations associated with a high probability of cancer development, vertical transmission through either mother or father, and an association with other types of tumors. They often have an early age of onset and exhibit an autosomal dominant inheritance pattern. Familial cancers share only some features of hereditary cancers. Although other cancers are associated with these hereditary syndromes, these guidelines mainly focus on management of breast and ovarian cancer risk in these individuals.
AB - All cancers develop as a result of mutations in certain genes, such as those involved in the regulation of cell growth and/or DNA repair, but not all mutations are inherited. However, family studies have long documented an increased risk for several forms of cancer among first and second-degree relatives . Hereditary cancers are often characterized by mutations associated with a high probability of cancer development, vertical transmission through either mother or father, and an association with other types of tumors. They often have an early age of onset and exhibit an autosomal dominant inheritance pattern. Familial cancers share only some features of hereditary cancers. Although other cancers are associated with these hereditary syndromes, these guidelines mainly focus on management of breast and ovarian cancer risk in these individuals.
KW - BRCA1
KW - BRCA2
KW - Breast/ovarian cancer syndrome
KW - Cowden syndrome
KW - Gene
KW - Genetic counseling
KW - Genetic risk assessment
KW - Hereditary
KW - Li-Fraumeni syndrome
KW - NCCN Clinical Practice Guidelines
UR - http://www.scopus.com/inward/record.url?scp=77952982796&partnerID=8YFLogxK
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:000279177500006&DestLinkType=FullRecord&DestApp=WOS
U2 - 10.6004/jnccn.2010.0043
DO - 10.6004/jnccn.2010.0043
M3 - Review article
C2 - 20495085
SN - 1540-1405
VL - 8
SP - 562
EP - 594
JO - Journal of the National Comprehensive Cancer Network : JNCCN
JF - Journal of the National Comprehensive Cancer Network : JNCCN
IS - 5
ER -